The impact of cinnarizine and griseofulvin on juvenile and adult stages of Schistosoma mansoni

Bibliographic Information
Authors: Sarhan R.M.; Thabet H.S.; Nazeer J.T.; William S.
Journal: Journal of Helminthology
Publisher: Cambridge University Press
Publication Date: 26 February 2019
Volume / Issue: Volume 94
Article No.: e41
ISSN: 0022149X
DOI: 10.1017/S0022149X19000178
Scopus: View on Scopus
PubMed: 30803454
Document Type: Article
Authors and Affiliations
Sarhan R.M., Faculty of Medicine, Ain Shams University, Cairo, Egypt; Thabet H.S., Faculty of Medicine, Ain Shams University, Cairo, Egypt; Nazeer J.T., Faculty of Medicine, Ain Shams University, Cairo, Egypt; William S., Theodor Bilharz Research Institute, Giza, Egypt
Abstract
Schistosomiasis affects millions globally. There is no vaccine, and treatment depends entirely on praziquantel (PZQ). Field isolates exhibit reduced susceptibility to PZQ, and resistance has been experimentally induced, suggesting that reliance on a single treatment is particularly dangerous. The present study investigated the value of cinnarizine and griseofulvin against Schistosoma mansoni through their in vitro effects on adult worms and oviposition as well as in vivo evaluation in early and late infection, compared to PZQ, in a preliminary experimental model. In vitro, both cinnarizine and griseofulvin showed uncoupling, sluggish worm movement and complete absence of ova at 100 μg/ml. In early infection, cinnarizine showed a significant reduction in the number of porto-mesenteric couples compared to the griseofulvin and control groups, a finding similar to PZQ. Remarkably, cinnarizine significantly exceeded PZQ and griseofulvin in reducing the total worm burden. In late infection, cinnarizine and griseofulvin showed results similar to PZQ by significantly reducing the numbers of hepatic and porto-mesenteric couples and total worm burden compared to controls. Cinnarizine performed better than griseofulvin by reducing hepatic and intestinal ovum counts, and it led to complete disappearance of the first two immature stages. The current work suggests the possibility of using cinnarizine and griseofulvin, mainly in late S. Mansoni infection, especially cinnarizine, which showed similar results to PZQ and surpassed it in early infection. Further studies are required to elucidate their exact mechanisms of action and particularly their synergistic effect with PZQ. Copyright © Cambridge University Press 2019Â.
Keywords
anthelmintic; cinnarizine; griseofulvin; in vitro; in vivo; praziquantel; Schistosoma mansoni; Animals; Anthelmintics; Female; Humans; Liver; Male; Mice; Schistosomiasis mansoni; anthelmintic agent; Article; comparative study; controlled study; egg laying; in vitro study; in vivo study; intestine tissue; liver tissue; nonhuman; scanning electron microscopy; Schistosoma; worm burden; animal; drug effect; growth, development and aging; human; mouse; parasitology
Citation Information
Scopus Citations: 4
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
